Equatorial Guinea vs Japan: Reported versus estimated cases of polio
Equatorial Guinea
0 cases
in 2023
Japan
0 cases
in 2023
Equatorial Guinea rank
26th
Japan rank
26th
Reported versus estimated cases of polio over time
- Equatorial Guinea
- Japan
How they compare
Equatorial Guinea currently reports 0 cases against 0 cases in Japan, a difference of 0 cases.
The two have swapped places 7 times across 38 shared years of data; in 1984 it was Equatorial Guinea ahead.
Equatorial Guinea ranks 26th and Japan ranks 26th of 199 countries.
Equatorial Guinea has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Japan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 5.17 cases | 0 cases | 5.17 cases | Equatorial Guinea |
| 1990s | 1.25 cases | 0 cases | 1.25 cases | Equatorial Guinea |
| 2000s | 0 cases | 0 cases | 0 cases | — |
| 2010s | 0.5 cases | 0 cases | 0.5 cases | Equatorial Guinea |
| 2020s | 0 cases | 0 cases | 0 cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported versus estimated cases of polio, Equatorial Guinea or Japan?
- Equatorial Guinea, at 0 cases against 0 cases in Japan as of 2023.
- What is the difference in reported versus estimated cases of polio between Equatorial Guinea and Japan?
- 0 cases, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Japan?
- 38 years are reported by both, from 1984 to 2023.
- How do Equatorial Guinea and Japan rank globally for reported versus estimated cases of polio?
- Equatorial Guinea ranks 26th and Japan ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported versus estimated cases of polio. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.